v3.26.1
EQUITY INVESTMENT - Schedule of Equity Method Investments (Details) - USD ($)
3 Months Ended 4 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2024
Nov. 11, 2025
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2025
Schedule of Equity Method Investments [Line Items]                      
Sales $ 26,143       $ 56,148       $ 258,802 $ 287,213  
Gross profit 22,533       49,817       171,748 261,705  
Net profit/(loss) (166,216) $ 1,112,684 $ (85,363) $ (222,196) (158,377) $ (193,702) $ (146,967)   861,105 (499,046)  
51% share 200       $ (22)       200 $ 2,123  
Net assets $ 167,105     301,817         $ 167,105   $ 301,817
Purecell Group [Member]                      
Schedule of Equity Method Investments [Line Items]                      
51% ownership       39,188       $ 32,692     39,188
Beginning balance of investment, May 11, 2021       5,450       5,450     5,450
Loss on equity investment – accumulated               (5,450)     (5,450)
Ending balance of investment       0       0     0
Purecell Group [Member]                      
Schedule of Equity Method Investments [Line Items]                      
Sales               0     32,042
Gross profit               0     32,042
Net profit/(loss)               (12,738)     (46,857)
51% share               (6,496)     (23,897)
Total assets       1,036,025       1,022,764     1,036,025
Net assets       $ 76,840       $ 64,101     $ 76,840